Figure 2From: Detecting acute neurotoxicity during platinum chemotherapy by neurophysiological assessment of motor nerve hyperexcitability Repetitive compound motor action potentials (CMAPs). (A) Normal CMAPs at baseline; (B) Repetitive CMAPs 46 hrs after oxaliplatin; (C) Proportion of patients and nerves affected by repetitive CMAPs by time relative to chemotherapy.Back to article page